Annual Operating Margin
-276.50%
-123.33%-80.52%
31 December 2023
Summary:
Lineage Cell Therapeutics annual operating profit margin is currently -276.50%, with the most recent change of -123.33% (-80.52%) on 31 December 2023. During the last 3 years, it has risen by +3144.85% (+91.92%). LCTX annual operating margin is now -136.63% below its all-time high of -116.85%, reached on 31 December 2007.LCTX Operating Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Margin
-101.61%
+315.08%+75.61%
30 September 2024
Summary:
Lineage Cell Therapeutics quarterly operating profit margin is currently -101.61%, with the most recent change of +315.08% (+75.61%) on 30 September 2024. Over the past year, it has increased by +436.51% (+81.12%). LCTX quarterly operating margin is now -120.76% below its all-time high of 489.49%, reached on 31 December 2011.LCTX Quarterly Operating Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LCTX Operating Margin Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -80.5% | +81.1% |
3 y3 years | +91.9% | +67.3% |
5 y5 years | +90.5% | +97.4% |
LCTX Operating Margin High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -80.5% | +91.9% | -9.3% | +96.5% |
5 y | 5 years | -80.5% | +91.9% | -9.3% | +98.4% |
alltime | all time | -136.6% | +100.0% | -120.8% | +100.0% |
Lineage Cell Therapeutics Operating Margin History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | -101.61%(-75.6%) |
June 2024 | - | -416.69%(-9.7%) |
Mar 2024 | - | -461.29%(+51.4%) |
Dec 2023 | -276.50%(+80.5%) | -304.69%(-43.4%) |
Sept 2023 | - | -538.12%(+245.4%) |
June 2023 | - | -155.78%(-44.0%) |
Mar 2023 | - | -278.37%(-19.7%) |
Dec 2022 | -153.17%(-87.9%) | -346.68%(+97.9%) |
Sept 2022 | - | -175.15%(+88.4%) |
June 2022 | - | -92.99%(-23.9%) |
Mar 2022 | - | -122.13%(-95.8%) |
Dec 2021 | -1263.12%(-63.1%) | -2941.46%(+846.5%) |
Sept 2021 | - | -310.76%(-80.6%) |
June 2021 | - | -1605.44%(-33.3%) |
Mar 2021 | - | -2406.14%(-32.1%) |
Dec 2020 | -3421.35%(+30.1%) | -3543.37%(+80.2%) |
Sept 2020 | - | -1966.37%(-69.6%) |
June 2020 | - | -6466.67%(+44.3%) |
Mar 2020 | - | -4480.72%(+442.5%) |
Dec 2019 | -2630.31%(-9.1%) | -825.96%(-78.7%) |
Sept 2019 | - | -3881.11%(-10.3%) |
June 2019 | - | -4328.40%(-39.3%) |
Mar 2019 | - | -7129.05%(+19.3%) |
Dec 2018 | -2895.13%(+27.6%) | -5973.68%(+52.3%) |
Sept 2018 | - | -3923.11%(+160.0%) |
June 2018 | - | -1508.91%(-50.3%) |
Mar 2018 | - | -3036.53%(+80.7%) |
Dec 2017 | -2268.75%(-13.4%) | -1680.67%(-18.2%) |
Sept 2017 | - | -2054.64%(-24.1%) |
June 2017 | - | -2708.14%(-8.9%) |
Mar 2017 | - | -2971.50%(+100.2%) |
Dec 2016 | -2618.43%(+0.8%) | -1484.56%(-39.4%) |
Sept 2016 | - | -2450.00%(-13.9%) |
June 2016 | - | -2846.44%(-29.8%) |
Mar 2016 | - | -4054.27%(+3.7%) |
Dec 2015 | -2597.04%(-0.2%) | -3909.91%(+92.0%) |
Sept 2015 | - | -2036.19%(-13.7%) |
June 2015 | - | -2359.44%(-1.3%) |
Mar 2015 | - | -2389.73%(-26.2%) |
Dec 2014 | -2603.08%(+93.3%) | -3236.18%(+44.8%) |
Sept 2014 | - | -2235.36%(-20.1%) |
June 2014 | - | -2797.00%(+23.3%) |
Mar 2014 | - | -2268.51%(+141.6%) |
Dec 2013 | -1346.63%(-8.8%) | -939.03%(-49.0%) |
Sept 2013 | - | -1842.74%(+18.7%) |
June 2013 | - | -1552.36%(-2.9%) |
Mar 2013 | - | -1598.77%(+17.4%) |
Dec 2012 | -1476.82%(+31.7%) | -1362.18%(+28.7%) |
Sept 2012 | - | -1058.26%(-37.1%) |
June 2012 | - | -1683.43%(-28.5%) |
Mar 2012 | - | -2352.99%(-580.7%) |
Dec 2011 | -1120.98%(+56.1%) | 489.49%(-234.3%) |
Sept 2011 | - | -364.37%(-42.9%) |
June 2011 | - | -638.29%(+30.7%) |
Mar 2011 | - | -488.21%(-215.7%) |
Dec 2010 | -718.25%(+292.8%) | 422.05%(-240.0%) |
Sept 2010 | - | -301.45%(-11.4%) |
June 2010 | - | -340.36%(+97.3%) |
Mar 2010 | - | -172.53%(-73.7%) |
Dec 2009 | -182.86%(-2.6%) | - |
Sept 2009 | - | -656.46%(+156.1%) |
June 2009 | - | -256.35%(-16.5%) |
Mar 2009 | - | -307.09%(-9.5%) |
Dec 2008 | -187.70% | -339.32%(+58.5%) |
Sept 2008 | - | -214.05%(-7.4%) |
Date | Annual | Quarterly |
---|---|---|
June 2008 | - | -231.23%(+116.4%) |
Mar 2008 | - | -106.84%(+48.8%) |
Dec 2007 | -116.85%(-22.5%) | -71.79%(+6.6%) |
Sept 2007 | - | -67.34%(-51.7%) |
June 2007 | - | -139.41%(-33.6%) |
Mar 2007 | - | -209.86%(+196.2%) |
Dec 2006 | -150.76%(-32.5%) | -70.85%(-32.0%) |
Sept 2006 | - | -104.21%(-76.7%) |
June 2006 | - | -447.77%(+134.8%) |
Mar 2006 | - | -190.73%(-8.2%) |
Dec 2005 | -223.47%(-21.9%) | -207.73%(+23.7%) |
Sept 2005 | - | -167.91%(-2.0%) |
June 2005 | - | -171.37%(-54.9%) |
Mar 2005 | - | -379.69%(+21.6%) |
Dec 2004 | -286.00%(-5.8%) | -312.24%(+27.9%) |
Sept 2004 | - | -244.13%(+6.5%) |
June 2004 | - | -229.32%(-40.7%) |
Mar 2004 | - | -386.76%(+161.3%) |
Dec 2003 | -303.70%(-42.2%) | -148.02%(-54.5%) |
Sept 2003 | - | -325.22%(-35.8%) |
June 2003 | - | -506.57%(+5.1%) |
Mar 2003 | - | -481.96%(+44.9%) |
Dec 2002 | -525.72%(-77.1%) | -332.55%(-10.1%) |
Sept 2002 | - | -369.97%(-60.8%) |
June 2002 | - | -942.72%(+0.9%) |
Mar 2002 | - | -934.29%(+14.0%) |
Dec 2001 | -2300.33%(-76.3%) | -819.28%(-68.1%) |
Sept 2001 | - | -2565.05%(-31.7%) |
June 2001 | - | -3756.68%(+28.2%) |
Mar 2001 | - | -2930.71%(+47.9%) |
Dec 2000 | -9697.25%(+1646.8%) | -1981.93%(-100.0%) |
Sept 2000 | - | -128.57 M%(>+9900.0%) |
June 2000 | - | -18.57 K%(-22.9%) |
Mar 2000 | - | -24.07 K%(+518.3%) |
Dec 1999 | -555.15%(-100.0%) | -3892.56%(-100.0%) |
Sept 1999 | - | -240.00 M%(>+9900.0%) |
June 1999 | - | -183.33%(-8.3%) |
Mar 1999 | - | -200.00%(-83.3%) |
Dec 1998 | -240.00 M%(>+9900.0%) | - |
Sept 1998 | - | -1200.00%(+1100.0%) |
June 1998 | - | -100.00%(-91.7%) |
June 1998 | -317.39%(-90.1%) | - |
Mar 1998 | - | -1200.00%(+433.3%) |
Dec 1997 | - | -225.00%(-79.5%) |
Sept 1997 | - | -1100.00%(+120.0%) |
June 1997 | -3200.00%(+60.0%) | - |
Mar 1997 | - | -500.00%(-28.6%) |
Dec 1996 | - | -700.00%(+16.7%) |
Sept 1996 | - | -600.00%(+50.0%) |
June 1996 | -2000.00%(-20.0%) | - |
Sept 1995 | - | -400.00%(-20.0%) |
June 1995 | -2500.00%(+56.3%) | - |
Mar 1995 | - | -500.00%(-16.7%) |
Dec 1994 | - | -600.00%(+50.0%) |
Sept 1994 | - | -400.00%(+100.0%) |
June 1994 | -1600.00%(+23.1%) | - |
Mar 1994 | - | -200.00%(-33.3%) |
Dec 1993 | - | -300.00%(0.0%) |
Sept 1993 | - | -300.00%(+50.0%) |
June 1993 | -1300.00%(+85.7%) | - |
Mar 1993 | - | -200.00%(-33.3%) |
Dec 1992 | - | -300.00%(+50.0%) |
Sept 1992 | - | -200.00%(+100.0%) |
June 1992 | -700.00% | - |
Mar 1992 | - | -100.00% |
FAQ
- What is Lineage Cell Therapeutics annual operating profit margin?
- What is the all time high annual operating margin for Lineage Cell Therapeutics?
- What is Lineage Cell Therapeutics annual operating margin year-on-year change?
- What is Lineage Cell Therapeutics quarterly operating profit margin?
- What is the all time high quarterly operating margin for Lineage Cell Therapeutics?
- What is Lineage Cell Therapeutics quarterly operating margin year-on-year change?
What is Lineage Cell Therapeutics annual operating profit margin?
The current annual operating margin of LCTX is -276.50%
What is the all time high annual operating margin for Lineage Cell Therapeutics?
Lineage Cell Therapeutics all-time high annual operating profit margin is -116.85%
What is Lineage Cell Therapeutics annual operating margin year-on-year change?
Over the past year, LCTX annual operating profit margin has changed by -123.33% (-80.52%)
What is Lineage Cell Therapeutics quarterly operating profit margin?
The current quarterly operating margin of LCTX is -101.61%
What is the all time high quarterly operating margin for Lineage Cell Therapeutics?
Lineage Cell Therapeutics all-time high quarterly operating profit margin is 489.49%
What is Lineage Cell Therapeutics quarterly operating margin year-on-year change?
Over the past year, LCTX quarterly operating profit margin has changed by +436.51% (+81.12%)